173 related articles for article (PubMed ID: 17027056)
1. Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066-1087) as the fusion peptide.
Plassmeyer ML; Soldan SS; Stachelek KM; Roth SM; Martín-García J; González-Scarano F
Virology; 2007 Feb; 358(2):273-82. PubMed ID: 17027056
[TBL] [Abstract][Full Text] [Related]
2. La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic.
Soldan SS; Hollidge BS; Wagner V; Weber F; González-Scarano F
Virology; 2010 Sep; 404(2):139-47. PubMed ID: 20553924
[TBL] [Abstract][Full Text] [Related]
3. Targeted Mutations in the Fusion Peptide Region of La Crosse Virus Attenuate Neuroinvasion and Confer Protection against Encephalitis.
Hollidge BS; Salzano MV; Ibrahim JM; Fraser JW; Wagner V; Leitner NE; Weiss SR; Weber F; González-Scarano F; Soldan SS
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891445
[TBL] [Abstract][Full Text] [Related]
4. California serogroup Gc (G1) glycoprotein is the principal determinant of pH-dependent cell fusion and entry.
Plassmeyer ML; Soldan SS; Stachelek KM; Martín-García J; González-Scarano F
Virology; 2005 Jul; 338(1):121-32. PubMed ID: 15923017
[TBL] [Abstract][Full Text] [Related]
5. The La Crosse virus class II fusion glycoprotein
Thannickal SA; Spector SN; Stapleford KA
J Virol; 2023 Aug; 97(8):e0081923. PubMed ID: 37578236
[TBL] [Abstract][Full Text] [Related]
6. Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes.
Bennett RS; Ton DR; Hanson CT; Murphy BR; Whitehead SS
Virol J; 2007 May; 4():41. PubMed ID: 17488515
[TBL] [Abstract][Full Text] [Related]
7. Effect of mixed infections of Sindbis and La Crosse viruses on replication of each virus in vitro.
Bara JJ; Muturi EJ
Acta Trop; 2014 Feb; 130():71-5. PubMed ID: 24463260
[TBL] [Abstract][Full Text] [Related]
8. The La Crosse virus class II fusion glycoprotein
Thannickal SA; Spector SN; Stapleford KA
bioRxiv; 2023 Feb; ():. PubMed ID: 36865275
[TBL] [Abstract][Full Text] [Related]
9. La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.
Bennett RS; Cress CM; Ward JM; Firestone CY; Murphy BR; Whitehead SS
Virol J; 2008 Feb; 5():25. PubMed ID: 18267012
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of infectivity of insect cell-derived La Crosse Virus by human serum.
Cruz MA; Parks GD
Virus Res; 2021 Jan; 292():198228. PubMed ID: 33188797
[TBL] [Abstract][Full Text] [Related]
11. Age influences susceptibility of brain capillary endothelial cells to La Crosse virus infection and cell death.
Basu R; Nair V; Winkler CW; Woods TA; Fraser IDC; Peterson KE
J Neuroinflammation; 2021 Jun; 18(1):125. PubMed ID: 34082753
[TBL] [Abstract][Full Text] [Related]
12. A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.
Bennett RS; Gresko AK; Nelson JT; Murphy BR; Whitehead SS
J Virol; 2012 Jan; 86(1):420-6. PubMed ID: 22013033
[TBL] [Abstract][Full Text] [Related]
13. La Crosse Virus Infection of Human Keratinocytes Leads to Interferon-Dependent Apoptosis of Bystander Non-Infected Cells In Vitro.
Cruz MA; Parks GD
Viruses; 2020 Feb; 12(3):. PubMed ID: 32106552
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent myeloid dendritic cell responses mediate resistance to la crosse virus-induced neurological disease.
Taylor KG; Woods TA; Winkler CW; Carmody AB; Peterson KE
J Virol; 2014 Oct; 88(19):11070-9. PubMed ID: 25008929
[TBL] [Abstract][Full Text] [Related]
15. Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening.
Sandler ZJ; Firpo MR; Omoba OS; Vu MN; Menachery VD; Mounce BC
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32284379
[TBL] [Abstract][Full Text] [Related]
16. Rottlerin inhibits La Crosse virus-induced encephalitis in mice and blocks release of replicating virus from the Golgi body in neurons.
Ojha D; Winkler CW; Leung JM; Woods TA; Chen CZ; Nair V; Taylor K; Yeh CD; Tawa GJ; Larson CL; Zheng W; Haigh CL; Peterson KE
Nat Microbiol; 2021 Nov; 6(11):1398-1409. PubMed ID: 34675384
[TBL] [Abstract][Full Text] [Related]
17. La Crosse Virus in Aedes japonicus japonicus mosquitoes in the Appalachian Region, United States.
Harris MC; Dotseth EJ; Jackson BT; Zink SD; Marek PE; Kramer LD; Paulson SL; Hawley DM
Emerg Infect Dis; 2015 Apr; 21(4):646-9. PubMed ID: 25811131
[TBL] [Abstract][Full Text] [Related]
18. Comparative sequence analyses of La Crosse virus strain isolated from patient with fatal encephalitis, Tennessee, USA.
Lambert AJ; Fryxell RT; Freyman K; Ulloa A; Velez JO; Paulsen D; Lanciotti RS; Moncayo A
Emerg Infect Dis; 2015 May; 21(5):833-6. PubMed ID: 25898269
[TBL] [Abstract][Full Text] [Related]
19. The spatial epidemiology and clinical features of reported cases of La Crosse virus infection in West Virginia from 2003 to 2007.
Haddow AD; Bixler D; Odoi A
BMC Infect Dis; 2011 Jan; 11():29. PubMed ID: 21269495
[TBL] [Abstract][Full Text] [Related]
20. La Crosse Virus Field Detection and Vector Competence of Culex Mosquitoes.
Harris MC; Yang F; Jackson DM; Dotseth EJ; Paulson SL; Hawley DM
Am J Trop Med Hyg; 2015 Sep; 93(3):461-7. PubMed ID: 26175029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
